Amber A Lagrew, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16455 Statesville Rd, Huntersville, NC 28078 Phone: 704-355-4645 Fax: 704-355-4231 |
Janelle Sullivan Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16405 Northcross Dr, Suite G-2, Huntersville, NC 28078 Phone: 704-439-3406 Fax: 480-393-4115 |
Lori A Eason, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16455 Statesville Rd, Huntersville, NC 28078 Phone: 704-801-3719 Fax: 704-801-3705 |
Mr. William F Cerosky, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 10315 Hamptons Park Dr, Huntersville, NC 28078 Phone: 704-323-2809 |
News Archive
The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.
If a colonoscopy seems like the type of thing you'd like to get done with quickly, think again. Research by a Veterans Affairs team has confirmed that longer-lasting colonoscopies are associated with lower cancer rates.
While falls are a common cause of injury, particularly in older, hospitalized patients, some may not be as preventable as once thought. According to a new literature review published in the Journal of the American Academy of Orthopaedic Surgeons, many of the risks that frequently cause falls are not adequately addressed with the fall prevention initiatives used in healthcare facilities.
Globally, the number of deaths from infections is on the rise as more bacteria become resistant to antibiotics.
POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.
› Verified 1 days ago